Thus, we measured plasma fibulin-3 concentrations by ELISA in TNBC patients (see Table 1 for patient demographics): newly diagnosed, non-metastatic TNBC (early disease), metastatic TNBC (advanced disease) and compared to healthy subjects (no prior history of breast cancer). The gene discussed is EFEMP1; the disease is breast carcinoma.